In this section of the page, you will find all the information you need to understand how Moderna (MRNA) dividends work. In addition, you will be able to consult the payment date, the ex-dividend date, the last day to be entitled to the payment, the money to be received per share, the yield and any other doubts that may arise.

Upcoming Moderna dividend
No change
Next payment N/A
Next payment date N/A
Last payment N/A
Last payment date N/A
00 D 00 H 00 M 00 S
Ex-Dividend: N/A
Not available

There is no upcoming dividend defined for Moderna.

There is no set last day on which buying Moderna shares generates the possibility of earning dividends.

There has been no final dividend for Moderna.

Moderna, listed on the American stock exchange under the ticker symbol MRNA, although to date it has not paid dividends to its shareholders and has not yet announced any change in this policy.

Payout Ratio Moderna Dividends

In the last fiscal period, Moderna paid no dividends, resulting in a dividend payout ratio of 0%.
Dividend payout ratio

The dividend payout ratio, also known as the payout ratio, is an essential indicator for assessing the stability of a company's dividends. This ratio shows what proportion of the company's net profit is used to pay dividends to shareholders.

Dividend payout ratio = Total dividends ÷ Net income

Moderna has not distributed dividends in the last fiscal period, therefore, the payout ratio is 0%.
Dividend payout ratio
General recommendations

An appropriate payout ratio may vary depending on the industry, the company's growth stage and its financial health.

Payout Ratio

Dividend calendar of Moderna

There is no Dividend Calendar of Moderna defined for 2023.

Historical annual dividend yields of Moderna

Over the past 5 years, Moderna has not consistently distributed dividends.
Increasing Dividends
Increasing Dividend Program

For a company to have growing dividends by our standards, the annual dividend amount must have increased steadily for at least the last 5 years.

Dividend yield

Dividend yield of Moderna vs. the sector

Moderna's dividend yield (0.00%) is in line with the industry average (0.00%).
Comparison with industry average
Comparison with industry average

The company's dividend yield is compared to the industry average to determine its positioning.

Moderna's dividend yield is among the top 25% (0.00%) of the sector.
Evaluation with respect to competence.
Comparison with competitors

Imagine you have a list of dividend yields for different companies in an industry. If you look for the "top 25%% percentile", you will find a number. This number tells you that the top 25%% of the companies with the highest dividends have a yield higher than that number.

On the other hand, the "top 75%% percentile" shows you another number, which tells you that 75%% of the companies have a higher yield than that number, thus showing a more common and less high yield.

Dividend yield history in Moderna

Over the past 5 years, Moderna has not consistently distributed dividends.
Dividend stability
Dividend stability

For a company to have stable dividends by our standards, it is vital that it has not had an annual decline of more than 10% over the previous year.

Dividend history of Moderna

Moderna has never distributed dividends, so it has an empty dividend history.

Moderna dividend capture strategy

Step 1: Buy Moderna shares (MRNA) one day before ex-dividend date
Date of purchase N/A
Next ex-dividend date N/A
Step 2: Sell Moderna shares (MRNA) when the price recovers.
Date of sale (estimated) N/A
Average price recovery N/A
Average return on cost N/A
The dividend capture strategy is based on historical Moderna data. Past performance is no guarantee of future results.

Information about Moderna

Full name Moderna, Inc.
Ticker MRNA
Sector Health Care
Industry Biotechnology
Market Capitalization 30.29B $
Number of Employees 3,900
Address 200 Technology Square, Cambridge, MA, 02139, United States
Phone 617 714 6500
Description of the company

Moderna, is a company dedicated to biotechnology and creation of drugs or vaccines based on the use of messenger RNA.

Its name is derived from the union between the words "modified" and "RNA", was founded in 2010 and begins its activities in 2011, conducted trials with other laboratories such as AstraZeneca, Mark and Alexion Pharmaceuticals, but in 2014 they decide to focus exclusively on their methodology and create vaccines based on mRNA.

In 2017 they create and commercialize the human vaccine mRNA-1653, with multivalent effect, protecting against human metapneumovirus (hMPV) and parainfluenza virus.

In 2020, because of the COVID-19 pandemic, they gained media attention by announcing that their experimental vaccine against the virus had successfully passed the first and second phase of the study by producing antibodies, although by then the possibility of generating side effects had not been controlled.

However, they were able to determine that if applied in low doses the adverse reactions (which could range from headache, fatigue, muscle pain to fever) decreased considerably, so it was studied with two doses of 100 mg administered at an interval of 29 days, obtaining approval in December of that year, being the second to be accepted worldwide.

Its headquarters are located in Massachusetts, United States, its business is mainly based on the insertion of the synthetic mRNA chain to live cells to try to reprogram them and develop an immune behavior, methodology used in previous opportunities by other laboratories, but abandoned for not being able to minimize the side effects that were generated, which is why, except for vaccines, the drugs produced by Moderna have not yet been approved to be marketed.

Frequently asked questions about Moderna dividends

Moderna is listed on the U.S. Technology Index and is part of the Nasdaq.

Moderna has the Ticker or stock code MRNA.

Moderna belongs to the Health Care sector and the Biotechnology industry.

The CEO of Moderna in 2023 is Mr. Stephane Bancel.

At this moment, the value of a Moderna share is 79.42$.

Moderna does not have a growing dividend program. Dividends have not shown a steady growth in the last 5 years.

Moderna Forum

Check the latest comments and participate in the live chat on Moderna stocks (MRNA).
Notify of

Inline Feedbacks
View all comments